WPD Pharmaceuticals Inc. (CSE:WBIO)

WPD Pharmaceuticals Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	0.01	0.09	0.02	0.3	1.24	2.95
Cash & Short-Term Investments	0.01	0.09	0.02	0.3	1.24	2.95
Cash Growth	-93.49%	260.85%	-92.10%	-75.69%	-58.02%	118857.60%
Other Receivables	0.04	0.03	0.05	0.03	0.04	0.22
Receivables	0.04	0.03	0.05	0.03	0.04	0.22
Prepaid Expenses	0	0	-	0.06	0.03	0.01
Restricted Cash	-	-	-	1.41	0.63	-
Total Current Assets	0.06	0.12	0.08	1.8	1.94	3.18
Property, Plant & Equipment	-	-	-	0.07	0.09	0.09
Long-Term Investments	0.24	0.22	-	-	-	0.48
Other Intangible Assets	-	-	-	-	0.66	0.33
Total Assets	0.29	0.35	0.08	1.86	2.68	4.07

Liabilities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Accounts Payable	0.46	0.53	0.45	1.62	0.8	0.61
Accrued Expenses	0.04	0.05	0.09	0.16	0.03	-
Short-Term Debt	0.02	-	-	1.03	0.09	0.19
Current Portion of Leases	-	-	-	0.02	0.02	0.06
Current Unearned Revenue	-	-	-	2.43	0.63	-
Other Current Liabilities	0.02	0.02	0.02	0.67	-	-
Total Current Liabilities	0.54	0.6	0.55	5.92	1.58	0.86
Long-Term Debt	0.37	0.3	-	-	-	-
Total Liabilities	0.91	0.9	0.55	5.92	1.58	0.86

Shareholders' Equity

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Common Stock	17.15	17.08	17.08	17.08	17.08	15.83
Retained Earnings	-22.14	-22.01	-21.93	-25.79	-20.17	-12.64
Comprehensive Income & Other	4.37	4.37	4.37	4.65	4.19	0.02
Shareholders' Equity	-0.62	-0.56	-0.48	-4.06	1.11	3.21
Total Liabilities & Equity	0.29	0.35	0.08	1.86	2.68	4.07

Additional Metrics

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Total Debt	0.39	0.3	-	1.04	0.12	0.25
Net Cash (Debt)	-0.38	-0.22	0.02	-0.74	1.12	2.7
Net Cash Growth	-	-	-	-	-58.34%	-
Net Cash Per Share	-0.08	-0.05	0.01	-0.16	0.25	19.73
Filing Date Shares Outstanding	4.64	4.54	4.54	4.54	4.54	4.54
Total Common Shares Outstanding	4.64	4.54	4.54	4.54	4.54	4.46
Working Capital	-0.49	-0.48	-0.48	-4.12	0.36	2.32
Book Value Per Share	-0.13	-0.12	-0.11	-0.89	0.24	0.72
Tangible Book Value	-0.62	-0.56	-0.48	-4.06	0.45	2.88
Tangible Book Value Per Share	-0.13	-0.12	-0.11	-0.89	0.10	0.65
Machinery	-	-	-	0.1	0.1	0.04

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 23, 2026

Data Sources Report a data error